ProShare Advisors Portfolio holdings
AUM
$50.1B
1-Year Return
23.39%
This Quarter Return
+3.89%
1 Year Return
+23.39%
3 Year Return
+95.6%
5 Year Return
+167.57%
10 Year Return
+417.51%
AUM
$16.7B
AUM Growth
+$10.2M
(+0.06%)
Cap. Flow
-$522M
Cap. Flow
% of AUM
-3.12%
Top 10 Holdings %
Top 10 Hldgs %
20.67%
Holding
1,686
New
28
Increased
245
Reduced
1,349
Closed
61
Top Buys
| 1 |
WBA
Walgreens Boots Alliance
WBA
|
+$23.4M |
| 2 |
Cardinal Health
CAH
|
+$16.7M |
| 3 |
Hormel Foods
HRL
|
+$16.3M |
| 4 |
Pentair
PNR
|
+$15.6M |
| 5 |
Becton Dickinson
BDX
|
+$15.5M |
Top Sells
| 1 |
Apple
AAPL
|
+$71.1M |
| 2 |
Microsoft
MSFT
|
+$59.9M |
| 3 |
Amazon
AMZN
|
+$51.6M |
| 4 |
Meta Platforms (Facebook)
META
|
+$25.6M |
| 5 |
Alphabet (Google) Class C
GOOG
|
+$20.6M |
Sector Composition
| 1 | Technology | 18.87% |
| 2 | Financials | 13.33% |
| 3 | Healthcare | 11.75% |
| 4 | Industrials | 10.98% |
| 5 | Consumer Staples | 10.87% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
901
Denali Therapeutics
DNLI
$2.17B
| $679K | ﹤0.01% |
32,689
-4,522
| -12% | -$93.9K |
|
902
First Solar
FSLR
$21.8B
| $676K | ﹤0.01% |
10,298
-516
| -5% | -$33.9K |
|
903
Enanta Pharmaceuticals
ENTA
$185M
| $673K | ﹤0.01% |
7,974
-905
| -10% | -$76.4K |
|
|
ATH
904
DELISTED
Athene Holding Ltd. Class A Common Shares
ATH
| $673K | ﹤0.01% |
15,633
-629
| -4% | -$27.1K |
|
905
Trustmark
TRMK
$2.44B
| $670K | ﹤0.01% |
20,164
-641
| -3% | -$21.3K |
|
906
Globus Medical
GMED
$8.05B
| $669K | ﹤0.01% |
15,812
-1,629
| -9% | -$68.9K |
|
907
Louisiana-Pacific
LPX
$6.81B
| $668K | ﹤0.01% |
25,470
-1,858
| -7% | -$48.7K |
|
|
AKCA
908
DELISTED
Akcea Therapeutics, Inc. Common Stock
AKCA
| $668K | ﹤0.01% |
28,507
-3,261
| -10% | -$76.4K |
|
909
Newell Brands
NWL
$2.55B
| $663K | ﹤0.01% |
42,980
-3,487
| -8% | -$53.8K |
|
910
Ironwood Pharmaceuticals
IRWD
$201M
| $660K | ﹤0.01% |
60,328
-20,661
| -26% | -$226K |
|
911
Popular Inc
BPOP
$8.43B
| $657K | ﹤0.01% |
12,106
-658
| -5% | -$35.7K |
|
912
Equitable Holdings
EQH
$16.1B
| $657K | ﹤0.01% |
31,436
+4,718
| +18% | +$98.6K |
|
913
Bio-Rad Laboratories Class A
BIO
$7.74B
| $651K | ﹤0.01% |
2,083
-397
| -16% | -$124K |
|
914
Encompass Health
EHC
$12.8B
| $651K | ﹤0.01% |
12,922
-2,397
| -16% | -$121K |
|
915
International Bancshares
IBOC
$4.43B
| $641K | ﹤0.01% |
16,991
-459
| -3% | -$17.3K |
|
|
TCDA
916
DELISTED
Tricida, Inc. Common Stock
TCDA
| $641K | ﹤0.01% |
16,246
-3
| -0% | -$118 |
|
|
BOLD
917
DELISTED
Audentes Therapeutics, Inc
BOLD
| $639K | ﹤0.01% |
16,877
-1,665
| -9% | -$63K |
|
|
CIT
918
DELISTED
CIT Group Inc.
CIT
| $636K | ﹤0.01% |
12,098
-815
| -6% | -$42.8K |
|
|
NUVA
919
DELISTED
NuVasive, Inc.
NUVA
| $634K | ﹤0.01% |
10,834
-1,104
| -9% | -$64.6K |
|
920
Erie Indemnity
ERIE
$17.7B
| $631K | ﹤0.01% |
2,481
-46
| -2% | -$11.7K |
|
921
Texas Capital Bancshares
TCBI
$4B
| $631K | ﹤0.01% |
10,288
-280
| -3% | -$17.2K |
|
922
LiveRamp
RAMP
$1.77B
| $630K | ﹤0.01% |
12,985
-336
| -3% | -$16.3K |
|
923
AXIS Capital
AXS
$7.76B
| $628K | ﹤0.01% |
10,527
-165
| -2% | -$9.84K |
|
|
AMED
924
DELISTED
Amedisys
AMED
| $625K | ﹤0.01% |
5,151
-164
| -3% | -$19.9K |
|
925
Helen of Troy
HELE
$567M
| $625K | ﹤0.01% |
4,783
-192
| -4% | -$25.1K |
|